Skip to main content
. 2016 Jul 28;34(2):180–188. doi: 10.1111/dme.13125

Figure 3.

Figure 3

(a) Confirmed hypoglycaemia over 26 weeks for insulin degludec/insulin aspart (IDegAsp) once daily and insulin glargine (IGlar) once daily). (b) Nocturnal confirmed hypoglycaemia over 26 weeks for IDegAsp once daily and IGlar once daily. ERR, estimated rate ratio.